The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis

In cystic fibrosis (CF), neutrophil-dominated airway inflammation results in high levels of neutrophil elastase (NE). Some of these proteases are sequestered by the large amounts of deoxyribonucleic acid (DNA) present in purulent sputum. Recombinant human deoxyribonuclease (rhDNase), a new treatment in CF, depolymerizes DNA. Our concerns were that this might release proteases bound to DNA, which could be potentially harmful. The in vitro and in vivo effects of rhDNase on NE and interleukin-8 (IL-8) were evaluated. The acute effects of rhDNase were evaluated in CF patients during the first 6 days of treatment. Medium-term effects were evaluated in stable CF patients observed in rhDNase over 6 months. Sputum samples were collected at regular intervals and NE activity was measured by a fluorimetric assay and IL-8 with a radioimmunoassay. In vitro addition of rhDNase resulted in a twofold increase in protease activity and this was reflected in an acute transient rise on initiation of treatment with rhDNase. Medium-term treatment was associated with a decline in NE activity and IL-8. These in vivo results are encouraging, since the increase in protease activity was transient and the trend over 6 months was a reduction in both inflammatory markers.

This article has been cited by other articles:

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				P. O. Jensen, T. Bjarnsholt, R. Phipps, T. B. Rasmussen, H. Calum, L. Christoffersen, C. Moser, P. Williams, T. Pressler, M. Givskov, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa Microbiology, May 1, 2007; 153(5): 1329 - 1338. [Abstract] [Full Text] [PDF]

				R. Bucki, F. J. Byfield, and P. A. Janmey Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum Eur. Respir. J., April 1, 2007; 29(4): 624 - 632. [Abstract] [Full Text] [PDF]

				M. A. Delgado, J. F. Poschet, and V. Deretic Nonclassical Pathway of Pseudomonas aeruginosa DNA-Induced Interleukin-8 Secretion in Cystic Fibrosis Airway Epithelial Cells. Infect. Immun., May 1, 2006; 74(5): 2975 - 2984. [Abstract] [Full Text] [PDF]

				R. L. Lee, R. C. Rancourt, G. del Val, K. Pack, C. Pardee, F. J. Accurso, and C. W. White Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L875 - L882. [Abstract] [Full Text] [PDF]

				K. Paul, E. Rietschel, M. Ballmann, M. Griese, D. Worlitzsch, J. Shute, C. Chen, T. Schink, G. Doring, S. van Koningsbruggen, et al. Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 719 - 725. [Abstract] [Full Text] [PDF]

				D. J. Weiner, R. Bucki, and P. A. Janmey The Antimicrobial Activity of the Cathelicidin LL37 Is Inhibited by F-actin Bundles and Restored by Gelsolin Am. J. Respir. Cell Mol. Biol., June 1, 2003; 28(6): 738 - 745. [Abstract] [Full Text] [PDF]

				B. PERKS and J. K. SHUTE DNA and Actin Bind and Inhibit Interleukin-8 Function in Cystic Fibrosis Sputa . In Vitro Effects of Mucolytics Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1767 - 1772. [Abstract] [Full Text]

				A. M. CANTIN DNase I Acutely Increases Cystic Fibrosis Sputum Elastase Activity and its Potential to Induce Lung Hemorrhage in Mice Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 464 - 469. [Abstract] [Full Text]